Trial Profile

Short term biological effects of Zoledronate and Letrozole on invasive breast cancer (pre-operative study)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Letrozole (Primary) ; Zoledronic acid (Primary)
Indications Advanced breast cancer
Focus Therapeutic Use

Most Recent Events

30 Jan 2014 According to United Kingdom Clinical Research Network record, status changed from active, no longer recruiting to completed.
24 Mar 2010 Results presented at the 7th European Breast Cancer Conference.
08 Jan 2010 United Kingdom Clinical Research Network reports accrual to date changed from 82% to 74%.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com